TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
FTH

Faeth Therapeutics, Inc.

Healthcare · Biotechnology

27.80$ -0.8% vs. previous close Closing price · As of: Sep 28, 2026

Investor relations

Report Dates

Investor relations overview for Faeth Therapeutics, Inc. (FTH): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/13/2026.

Next report 11/13/2026
Last report 08/04/2026
Earnings surprise by quarter (%)
Q3 23 · 17.7 % 23 Q4 23 · 2.1 % 23 Q2 24 · -2.0 % 24 Q3 24 · 9.1 % 24 Q4 24 · 5.9 % 24 Q2 25 · 21.8 % 25 Q3 25 · 11.9 % 25 Q4 25 · 22.3 % 25 Q1 26 · -21,101.6 % 26 Q2 26 · -158.2 % 26

EPS estimate beaten

Full history 11 of 18 quarters (61%)
Last 16 quarters 11 of 16 quarters (69%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/17/2026 Faeth Therapeutics, Inc. (FTH): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?